MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Offizielle URL: https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-systemische-therapie-substanzen-2019 | Version: 2027.0.0-ballot.1 | |||
| Active Stand: 2026-09-15 | Maschinenlesbarer Name: MII_VS_Onko_Systemische_Therapie_Substanzen_2019 | |||
ATC-Codes für Substanzen der systemischen Therapie, validiert gegen ATC-DE Version 2019. Für historische Datenvalidierung.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Profiles: Shareable ValueSet, CRMI Shareable ValueSet, CRMI Publishable ValueSet, CRMI Computable ValueSet
http://fhir.de/CodeSystem/bfarm/atc version 📍2019| Code | Display |
| L02BX01 | Abarelix |
| L04AA24 | Abatacept |
| L04AA22 | Abetimus |
| L02BX03 | Abirateron |
| L01DB04 | Aclarubicin |
| L04AB04 | Adalimumab |
| L01XE13 | Afatinib |
| L04AB03 | Afelimomab |
| L01XX44 | Aflibercept |
| L03AC01 | Aldesleukin |
| L01XE36 | Alectinib |
| L04AA15 | Alefacept |
| L04AA34 | Alemtuzumab |
| M05BA04 | Alendronsäure |
| L01XX22 | Alitretinoin |
| L01XX03 | Altretamin |
| V03AM01 | Amilomer |
| L02BG01 | Aminoglutethimid |
| L01XD04 | Aminolevulinsäure |
| L01DB10 | Amrubicin |
| L01XX01 | Amsacrin |
| L01XX35 | Anagrelid |
| L04AC03 | Anakinra |
| L02BG03 | Anastrozol |
| L04AA04 | Antithymozytäres Immunglobulin (Kaninchen) |
| L01XX27 | Arsentrioxid |
| P01BE03 | Artesunat |
| L01XX02 | Asparaginase |
| L01XC32 | Atezolizumab |
| L01XC31 | Avelumab |
| L01XE17 | Axitinib |
| L01BC07 | Azacitidin |
| L04AX01 | Azathioprin |
| L04AC02 | Basiliximab |
| L03AX03 | BCG-Impfstoff |
| L04AA28 | Belatacept |
| L04AA26 | Belimumab |
| L01XX49 | Belinostat |
| L01AA09 | Bendamustin |
| L01XC07 | Bevacizumab |
| L01XX25 | Bexaroten |
| L02BB03 | Bicalutamid |
| L01XE41 | Binimetinib |
| L01DC01 | Bleomycin |
| L01XC19 | Blinatumomab |
| L01XX32 | Bortezomib |
| L01XE14 | Bosutinib |
| L01XC12 | Brentuximab vedotin |
| L04AC09 | Briakinumab |
| L01XE43 | Brigatinib |
| N04BC01 | Bromocriptin |
| L02AE01 | Buserelin |
| L01AB01 | Busulfan |
| L01CD04 | Cabazitaxel |
| N04BC06 | Cabergolin |
| L01XE26 | Cabozantinib |
| V03AF04 | Calciumlevofolinat |
| L04AC08 | Canakinumab |
| L01BC06 | Capecitabin |
| L01XA02 | Carboplatin |
| L01AC03 | Carboquon |
| L01XX45 | Carfilzomib |
| L01BC04 | Carmofur |
| L01AD01 | Carmustin |
| L01XE28 | Ceritinib |
| L04AB05 | Certolizumab pegol |
| H01CC02 | Cetrorelix |
| L01XC06 | Cetuximab |
| L01AA02 | Chlorambucil |
| G03DB06 | Chlormadinon |
| L01AA05 | Chlormethin |
| L04AD01 | Ciclosporin |
| L01XA01 | Cisplatin |
| L01BB04 | Cladribin |
| M05BA02 | Clodronsäure |
| L01BB06 | Clofarabin |
| L01XE38 | Cobimetinib |
| L01XE16 | Crizotinib |
| L01AA01 | Cyclophosphamid |
| G03HA01 | Cyproteron |
| L01BC01 | Cytarabin |
| L01XY01 | Cytarabin und Daunorubicin |
| L01XE23 | Dabrafenib |
| L01AX04 | Dacarbazin |
| L04AC01 | Daclizumab |
| L01DA01 | Dactinomycin |
| L01XC24 | Daratumumab |
| B03XA02 | Darbepoetin alfa |
| L01XE06 | Dasatinib |
| L01DB02 | Daunorubicin |
| L01BC08 | Decitabin |
| L02BX02 | Degarelix |
| L01CC01 | Demecolcin |
| L01XX29 | Denileukindiftitox |
| M05BX04 | Denosumab |
| H02AB02 | Dexamethason |
| L01CD02 | Docetaxel |
| L01DB01 | Doxorubicin |
| L01XC28 | Durvalumab |
| G04CB02 | Dutasterid |
| L04AA25 | Eculizumab |
| L04AA21 | Efalizumab |
| L01XD06 | Efaproxiral |
| B02BX05 | Eltrombopag |
| L01XX59 | Enasidenib |
| L01XE46 | Encorafenib |
| L02BB04 | Enzalutamid |
| L01DB03 | Epirubicin |
| L01XX41 | Eribulin |
| L01XE03 | Erlotinib |
| B03XA01 | Erythropoietin |
| L01XX11 | Estramustin |
| L04AB01 | Etanercept |
| M05BA01 | Etidronsäure |
| L01AG01 | Etoglucid |
| L01CB01 | Etoposid |
| L01XE10 | Everolimus |
| L02BG06 | Exemestan |
| L03AA02 | Filgrastim |
| G04CB01 | Finasterid |
| L04AA27 | Fingolimod |
| L01BC09 | Floxuridin |
| L01BB05 | Fludarabin |
| L01BC02 | Fluorouracil |
| L01BC52 | Fluorouracil, Kombinationen |
| L02BB01 | Flutamid |
| V03AF03 | Calciumfolinat |
| L02BG02 | Formestan |
| L02AA04 | Fosfestrol |
| L01AD05 | Fotemustin |
| L02BA03 | Fulvestrant |
| L01XE02 | Gefitinib |
| L01BC05 | Gemcitabin |
| L02AB03 | Gestonoron |
| L04AB06 | Golimumab |
| H01CA01 | Gonadorelin |
| L02AE03 | Goserelin |
| L04AA19 | Gusperimus |
| L03AX14 | Histamindihydrochlorid |
| L02AE05 | Histrelin |
| L01XX05 | Hydroxycarbamid |
| M05BA06 | Ibandronsäure |
| V10XX02 | (90Y)Ibritumomabtiuxetan |
| L01XE27 | Ibrutinib |
| L01DB06 | Idarubicin |
| L01XX47 | Idelalisib |
| L01AA06 | Ifosfamid |
| L01XE01 | Imatinib |
| D06BB10 | Imiquimod |
| L04AB02 | Infliximab |
| D06BX02 | Ingenolmebutat |
| L01XC26 | Inotuzumab ozogamicin |
| L03AB01 | Interferon alfa, natürlich |
| L03AB04 | Interferon alfa-2a |
| L03AB05 | Interferon alfa-2b |
| L03AB18 | Interferon gamma-1b |
| L01XC11 | Ipilimumab |
| L01XX19 | Irinotecan |
| L01DC04 | Ixabepilon |
| L01XX50 | Ixazomib |
| H01CB03 | Lanreotid |
| L01XE07 | Lapatinib |
| L04AA13 | Leflunomid |
| L04AX04 | Lenalidomid |
| L03AA10 | Lenograstim |
| L01XE29 | Lenvatinib |
| L02BG04 | Letrozol |
| L02AE02 | Leuprorelin |
| L03AA14 | Lipegfilgrastim |
| L01AD02 | Lomustin |
| L01XX07 | Lonidamin |
| L01XE44 | Lorlatinib |
| G03DC03 | Lynestrenol |
| L01AB03 | Mannosulfan |
| J05AX09 | Maraviroc |
| L01XX10 | Masoprocol |
| L02AB02 | Medroxyprogesteron |
| L02AB01 | Megestrol |
| L01AA03 | Melphalan |
| R03DX09 | Mepolizumab |
| L01BB02 | Mercaptopurin |
| V03AF01 | Mesna |
| N07BC02 | Methadon |
| L01BA01 | Methotrexat |
| L01XD10 | Methoxsalen |
| B03XA03 | Methoxy-Polyethylenglycol-Epoetin beta |
| L01XD03 | Methylaminolevulinat |
| H02AB04 | Methylprednisolon |
| L01XE39 | Midostaurin |
| L03AX15 | Mifamurtid |
| L01XX09 | Miltefosin |
| L01CH01 | Mistelkraut |
| L01CP01 | Mistelkraut |
| L01AX01 | Mitobronitol |
| L01XX16 | Mitoguazon |
| L01DC03 | Mitomycin |
| L01XX23 | Mitotan |
| L01DB07 | Mitoxantron |
| L03AA03 | Molgramostim |
| L04AA02 | Muromonab-CD3 |
| L04AA06 | Mycophenolsäure |
| L04AA23 | Natalizumab |
| V03AF10 | Natriumlevofolinat |
| L01BB07 | Nelarabin |
| L01XE45 | Neratinib |
| L01XE08 | Nilotinib |
| L02BB02 | Nilutamid |
| L01AD06 | Nimustin |
| L01XE31 | Nintedanib |
| L01XX54 | Niraparib |
| L01XC17 | Nivolumab |
| L01XC15 | Obinutuzumab |
| L01XX36 | Oblimersen |
| H01CB02 | Octreotid |
| L01XX46 | Olaparib |
| L01XC27 | Olaratumab |
| L01XX40 | Omacetaxinmepesuccinat |
| L03AC02 | Oprelvekin |
| L01XE35 | Osimertinib |
| L01XA03 | Oxaliplatin |
| L01CD01 | Paclitaxel |
| L01CD03 | Paclitaxelpoliglumex |
| L01XE33 | Palbociclib |
| V03AF08 | Palifermin |
| M05BA03 | Pamidronsäure |
| L01XC08 | Panitumumab |
| L01XX42 | Panobinostat |
| L01XX24 | Pegaspargase |
| L03AA13 | Pegfilgrastim |
| L03AB11 | Peginterferon alfa-2a |
| L03AB10 | Peginterferon alfa-2b |
| L01XC18 | Pembrolizumab |
| L01BA04 | Pemetrexed |
| L01XX08 | Pentostatin |
| L01XC13 | Pertuzumab |
| L01AX02 | Pipobroman |
| L01DB08 | Pirarubicin |
| L01DB11 | Pixantron |
| V03AX10 | Placebo |
| L03AX16 | Plerixafor |
| L01DC02 | Plicamycin |
| L03AX08 | Poly ICLC |
| L02AA02 | Polyestradiolphosphat |
| L01XA05 | Polyplatillen |
| L04AX06 | Pomalidomid |
| L01XE24 | Ponatinib |
| L01XD01 | Porfimer natrium |
| L01BA05 | Pralatrexat |
| D07AC18 | Prednicarbat |
| L01AA08 | Prednimustin |
| H02AB06 | Prednisolon |
| H02AB07 | Prednison |
| L01XB01 | Procarbazin |
| D05AD | Psoralene zur topischen Anwendung |
| D05BA | Psoralene zur systemischen Anwendung |
| G03XC01 | Raloxifen |
| L01BA03 | Raltitrexed |
| L01XC21 | Ramucirumab |
| L01AD07 | Ranimustin |
| L01XE21 | Regorafenib |
| L01XE42 | Ribociclib |
| L04AC04 | Rilonacept |
| M05BA07 | Risedronsäure |
| L01XC02 | Rituximab |
| L01XX39 | Romidepsin |
| B02BX04 | Romiplostim |
| L03AB15 | Ropeginterferon alfa-2b |
| L01XE18 | Ruxolitinib |
| L01XA04 | Satraplatin |
| L01AD03 | Semustin |
| L04AC11 | Siltuximab |
| L04AA10 | Sirolimus |
| H01CB01 | Somatostatin |
| L01XE05 | Sorafenib |
| L01AD04 | Streptozocin |
| L01XE04 | Sunitinib |
| L04AD02 | Tacrolimus |
| L01XX51 | Talimogen laherparepvec |
| L02BA01 | Tamoxifen |
| L03AX11 | Tasonermin |
| L01BC53 | Tegafur, Kombinationen |
| L01BC63 | Tegafur und Uracil |
| L01BC73 | Tegafur, Gimeracil und Oteracil |
| L01XD05 | Temoporfin |
| L01AX03 | Temozolomid |
| L01XE09 | Temsirolimus |
| L01CB02 | Teniposid |
| L04AX02 | Thalidomid |
| L01AC01 | Thiotepa |
| L01XX18 | Tiazofurin |
| M05BA05 | Tiludronsäure |
| L01BB03 | Tioguanin |
| L01XE34 | Tivozanib |
| L04AC07 | Tocilizumab |
| L01XX17 | Topotecan |
| L02BA02 | Toremifen |
| V10XA53 | Tositumomab/(131I)Iodtositumomab |
| L01CX01 | Trabectedin |
| L01XE25 | Trametinib |
| L01XC03 | Trastuzumab |
| L01XC14 | Trastuzumab emtansin |
| L01AB02 | Treosulfan |
| L01XX14 | Tretinoin |
| L01AC02 | Triaziquon |
| L01BC59 | Trifluridin, Kombinationen |
| L02AE04 | Triptorelin |
| L01AA07 | Trofosfamid |
| L01AD08 | Uramustin |
| N03AG01 | Valproinsäure |
| L01DB09 | Valrubicin |
| L01XE12 | Vandetanib |
| L01XE15 | Vemurafenib |
| L01XX52 | Venetoclax |
| L01CA01 | Vinblastin |
| L01CA02 | Vincristin |
| L01CA03 | Vindesin |
| L01CA05 | Vinflunin |
| L01CA04 | Vinorelbin |
| L01XX43 | Vismodegib |
| L04AD03 | Voclosporin |
| L01XX38 | Vorinostat |
| L02BG05 | Vorozol |
| L01XX53 | Vosaroxin |
| M05BA08 | Zoledronsäure |
| L01DB05 | Zorubicin |
Expansion from 127.0.0.1 based on codesystem atc version 2019
This value set contains 325 concepts